Possible Symptoms Fatigue, weakness, reduced exercise tolerance, or shortness of breath Pale or yellow-tinged skin A sore, smooth, or inflamed tongue Numbness, tingling, burning, or altered sensation in the hands or feet Balance problems, unsteady walking, or reduced coordination Memory difficulty, concentration changes, confusion, or mood symptoms Palpitations related to anemia Unexplained weight loss or appetite changes Do not delay care for neurologic symptoms New numbness, weakness, walking difficulty, balance loss, confusion, vision change, or bowel/bladder neurologic symptoms require prompt medical evaluation
Monitoring Weeks 1-2 : Energy, sites 3-4 : Composition, sleep 5+ : Progress, markers Optimal signs : Steady energy, fat loss, performance gains, no jitters
Both of these injections are used for separate purposes and have different formulations, despite the common misconception that they are the same
PT-141 is a synthetic cyclic heptapeptide melanocortin receptor agonist (alpha-MSH analog)
doi: 10.1155/2014/151479